Unknown

Dataset Information

0

Protective and antifungal properties of Nanodisk-Amphotericin B over commercially available Amphotericin B.


ABSTRACT: Objective:Amphotericin B (AMB), a potent antifungal agent, has been employed as topical and systemic therapy for sinonasal fungal infections. A novel formulation of nanodisc (ND) containing super aggregated AMB (ND-AMB) for the treatment of fungal infections has been recently developed to provide greater protection from AMB toxicity than current, clinically approved lipid-based formulations. The objective of the current study was to evaluate the safety and potency of ND-AMB for sinonasal delivery using an in vitro model. Methods:Human sinonasal tissue was harvested during endoscopic sinus surgery and grown at air-liquid interface until well-differentiated. Cultures were exposed to ND-AMB vs AMB and changes in K+ permeability and resistance were measured and recorded via Ussing chamber assay. Ciliary beat frequency (CBF) was analyzed in parallel as well as cytotoxic assay. Potency was assessed using real-time PCR measurement of the Aspergillus fumigatus 18S rRNA. Results:Ussing chamber studies revealed K+ currents that increased rapidly within 30 s of adding AMB (10 ?g/mL) to the apical side, indicating apical membranes had become permeable to K+ ions. In contrast, negligible induction of K+ current was obtained following addition of ND-AMB [AMB = (107.7 ± 15.9) ?A/cm2 AMB vs ND-AMB = (2.3 ± 0.7) ?A/cm2 ND-AMB; P = 0.005]. ND-AMB also protected nasal epithelial cells from cytotoxicity of AMB (P < 0.05). There was no difference in ciliary beat frequency between the two groups (P = 0.96). The expression of A. fumigatus 18S rRNA with exposure of lower dose of ND-AMB was significantly lower compared to that with AMB (P < 0.05). Conclusions:Data from the present study suggests ND-AMB protects human nasal epithelia membranes from AMB toxicity by protecting against apical cell K+ permeability while maintaining uncompromised antifungal property compared to AMB. ND-AMB could provide a novel topical therapy for sinonasal fungal diseases.

SUBMITTER: Cho DY 

PROVIDER: S-EPMC5683641 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Protective and antifungal properties of Nanodisk-Amphotericin B over commercially available Amphotericin B.

Cho Do-Yeon DY   Hoffman Kyle J KJ   Gill Gobind S GS   Lim Dong-Jin DJ   Skinner Daniel D   Mackey Calvin C   Rowe Steven M SM   Woodworth Bradford A BA  

World journal of otorhinolaryngology - head and neck surgery 20170307 1


<h4>Objective</h4>Amphotericin B (AMB), a potent antifungal agent, has been employed as topical and systemic therapy for sinonasal fungal infections. A novel formulation of nanodisc (ND) containing super aggregated AMB (ND-AMB) for the treatment of fungal infections has been recently developed to provide greater protection from AMB toxicity than current, clinically approved lipid-based formulations. The objective of the current study was to evaluate the safety and potency of ND-AMB for sinonasal  ...[more]

Similar Datasets

| S-EPMC8393184 | biostudies-literature
2021-08-01 | GSE156973 | GEO
| S-EPMC4834613 | biostudies-other
| S-EPMC10988267 | biostudies-literature
2019-09-27 | GSE133719 | GEO
| S-EPMC4845298 | biostudies-other
| S-EPMC8374640 | biostudies-literature
| S-EPMC8102868 | biostudies-literature
| S-EPMC10665233 | biostudies-literature
| PRJNA474334 | ENA